## NSAID-Induced Peptic Ulcer Disease: Management Principles ### Epidemiology and Pathophysiology **Key Point:** NSAID-induced ulcers account for ~25% of peptic ulcer disease in developed countries. However, H. pylori co-infection occurs in ~20–30% of NSAID users and significantly increases ulcer risk and complications. ### H. pylori Testing in NSAID-Induced Ulcers **High-Yield:** H. pylori testing is NOT unnecessary and SHOULD be performed in all patients with NSAID-induced ulcers. If H. pylori is present, eradication therapy is indicated in addition to PPI therapy. The combination of H. pylori + NSAIDs dramatically increases ulcer recurrence and complication risk. ### Management Algorithm for NSAID-Induced Ulcers ```mermaid flowchart TD A[NSAID-induced ulcer diagnosed]:::outcome --> B{H. pylori status?}:::decision B -->|Positive| C[Eradication therapy + PPI]:::action B -->|Negative| D[PPI monotherapy]:::action E[Continue NSAID?]:::decision C --> E D --> E E -->|Yes - essential| F[Continue PPI long-term]:::action E -->|No| G[Discontinue NSAID, taper PPI]:::action F --> H[Reduce ulcer recurrence]:::outcome ``` ### Comparison of Preventive Strategies | Strategy | Efficacy | Tolerability | Notes | |----------|----------|---|---| | **PPI monotherapy** | Excellent (>95% healing) | Excellent | First-line; long-term use safe | | **Misoprostol** | Excellent (prevents ulcers) | Poor (diarrhea 20–30%) | Effective but poorly tolerated | | **H~2~-receptor antagonist** | Moderate (less effective than PPI) | Good | Not preferred for NSAID prevention | | **COX-2 selective inhibitor + PPI** | Superior to non-selective NSAID + PPI | Good | Reduces ulcer risk by ~50% vs traditional NSAID | ### Why Option 1 is Incorrect (The Correct Answer) **Clinical Pearl:** The statement "Testing for H. pylori is unnecessary in this patient because NSAID-induced ulcers are not associated with H. pylori infection" is FALSE. Although NSAID-induced ulcers are mechanically distinct from H. pylori–induced ulcers, co-infection is common (~20–30%) and significantly worsens prognosis. H. pylori testing is mandatory. ### Why Other Options Are Correct **Option 0 (TRUE):** PPIs are first-line therapy. If the NSAID must be continued (as in this patient with CAD on aspirin), PPI therapy should be maintained long-term to prevent recurrence. **Option 2 (TRUE):** Misoprostol is highly effective for prevention but causes dose-limiting diarrhea in 20–30% of patients, limiting its use. **Option 3 (TRUE):** COX-2 selective inhibitors (e.g., celecoxib) have lower ulcerogenicity than non-selective NSAIDs. When combined with PPI, they reduce recurrent ulcer risk. [cite:Harrison 21e Ch 297]
Sign up free to access AI-powered MCQ practice with detailed explanations and adaptive learning.